We’re a biotech company founded in 2020 to discover and develop next-generation off-the-shelf allogeneic cell therapies for patients.
Just as the first Roman aqueduct Aqua Appia was a highly sophisticated feat of engineering built to serve more people, so too is our cellular technology platform - ACUA.
Our mission is to create novel, curative, and accessible cell therapies for patients.
Our vision is to be the leading cell therapy company transforming patients' lives through the passionate pursuit of innovation and excellence.
